NYSE:MLSS Milestone Scientific (MLSS) Stock Forecast, Price & News $0.90 -0.02 (-2.17%) (As of 09/27/2023 ET) Add Compare Share Share Today's Range$0.90▼$0.9450-Day Range$0.92▼$1.3152-Week Range$0.41▼$1.35Volume51,680 shsAverage Volume92,366 shsMarket Capitalization$64.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media About Milestone Scientific (NYSE:MLSS) StockMilestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.Read More MLSS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MLSS Stock News HeadlinesSeptember 21, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)September 12, 2023 | finance.yahoo.comMilestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of DirectorsSeptember 28, 2023 | Chaikin Analytics (Ad)Buy This Stock for AI Tidal Wave (not NVDA)The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.September 12, 2023 | finance.yahoo.comMilestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of DirectorsAugust 15, 2023 | msn.comMilestone Scientific GAAP EPS of -$0.03 misses by $0.01, revenue of $2.9M beats by $0.23MAugust 15, 2023 | finance.yahoo.comMilestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023August 12, 2023 | bizjournals.comSunRail passes 1M annual riders for 1st time since pre-CovidAugust 9, 2023 | finance.yahoo.comMilestone Scientific Schedules Second Quarter 2023 Financial Results and Business Update Conference CallSeptember 28, 2023 | Chaikin Analytics (Ad)Buy This Stock for AI Tidal Wave (not NVDA)The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.August 9, 2023 | finance.yahoo.comMilestone Scientific Announces Positive Insurance Payment for the CompuFlo® Epidural SystemJuly 22, 2023 | finanznachrichten.deLUCY SCIENTIFIC DISCOVERY INCJune 15, 2023 | msn.comMilestone Scientific: Buy For The $4 Billion Total Addressable MarketJune 15, 2023 | finance.yahoo.comMilestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20thJune 11, 2023 | msn.comMilestone Scientific: Sales Could Start To SnowballMay 16, 2023 | finance.yahoo.comMilestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, CaliforniaMay 16, 2023 | finance.yahoo.comMilestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, CaliforniaMay 12, 2023 | msn.comRecap: Milestone Scientific Q1 EarningsMay 11, 2023 | finanznachrichten.deMilestone Scientific, Inc.: Milestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023May 11, 2023 | finance.yahoo.comMilestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023May 11, 2023 | finance.yahoo.comMilestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023May 10, 2023 | finance.yahoo.comMilestone Scientific Announces Successful Epidural Steroid Injection Procedures Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain Management SurgeryMay 9, 2023 | finance.yahoo.comMilestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the Sports and Spine Clinic in OregonMay 5, 2023 | finance.yahoo.comMilestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference CallApril 4, 2023 | markets.businessinsider.comMaxim Group Reaffirms Their Buy Rating on Milestone Scientific (MLSS)April 4, 2023 | finance.yahoo.comMilestone Scientific Inc. (AMEX:MLSS) Q4 2022 Earnings Call TranscriptMarch 31, 2023 | finanznachrichten.deMilestone Scientific, Inc.: Milestone Scientific Provides 2022 Year-End Business UpdateMarch 31, 2023 | finance.yahoo.comMilestone Scientific Provides 2022 Year-End Business UpdateSee More Headlines Receive MLSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address MLSS Company Calendar Last Earnings8/15/2023Today9/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNYSE:MLSS CUSIPN/A CIK855683 Webwww.milestonescientific.com Phone(973) 535-2717Fax973-535-2829Employees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,710,000.00 Net Margins-74.96% Pretax Margin-75.47% Return on Equity-78.34% Return on Assets-57.02% Debt Debt-to-Equity RatioN/A Current Ratio3.38 Quick Ratio2.67 Sales & Book Value Annual Sales$9.96 million Price / Sales6.73 Cash FlowN/A Price / Cash FlowN/A Book Value$0.15 per share Price / Book6.27Miscellaneous Outstanding Shares71,366,000Free Float53,382,000Market Cap$67.08 million OptionableOptionable Beta1.32 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Jan Adriaan Haverhals (Age 61)Pres, CEO & Director Comp: $624.76kMr. Leonard A. Osser (Age 76)Founder, MD of China Operations & Director Mr. Andy Molnar (Age 61)Sr. VP of Global Sales & Bus. Devel. for Dental Keisha HarcumControllerKey CompetitorsCollPlant BiotechnologiesNASDAQ:CLGNVicarious SurgicalNYSE:RBOTEargoNASDAQ:EARReWalk RoboticsNASDAQ:RWLKOceanTech Acquisitions INASDAQ:OTECView All CompetitorsInsiders & InstitutionsGeode Capital Management LLCBought 47,777 shares on 8/11/2023Ownership: 0.591%Northern Trust CorpBought 9,272 shares on 8/11/2023Ownership: 0.136%BlackRock Inc.Sold 102,827 shares on 8/11/2023Ownership: 0.132%Charles Schwab Investment Management Inc.Bought 34,400 shares on 8/10/2023Ownership: 0.049%Simplex Trading LLCBought 2,000 shares on 8/4/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions MLSS Stock - Frequently Asked Questions How have MLSS shares performed in 2023? Milestone Scientific's stock was trading at $0.48 on January 1st, 2023. Since then, MLSS shares have increased by 95.8% and is now trading at $0.9399. View the best growth stocks for 2023 here. How were Milestone Scientific's earnings last quarter? Milestone Scientific Inc. (NYSE:MLSS) issued its quarterly earnings results on Tuesday, August, 15th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The company had revenue of $2.91 million for the quarter. Milestone Scientific had a negative net margin of 74.96% and a negative trailing twelve-month return on equity of 78.34%. What other stocks do shareholders of Milestone Scientific own? Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and What is Milestone Scientific's stock symbol? Milestone Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "MLSS." Who are Milestone Scientific's major shareholders? Milestone Scientific's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (0.59%), Northern Trust Corp (0.14%), BlackRock Inc. (0.13%), Charles Schwab Investment Management Inc. (0.05%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Giandomenico Trombetta, Joseph D'agostino, Leonard Osser, Leslie Bernhard and Neal I Goldman. View institutional ownership trends. How do I buy shares of Milestone Scientific? Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Milestone Scientific's stock price today? One share of MLSS stock can currently be purchased for approximately $0.94. How much money does Milestone Scientific make? Milestone Scientific (NYSE:MLSS) has a market capitalization of $67.08 million and generates $9.96 million in revenue each year. The company earns $-8,710,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. How can I contact Milestone Scientific? Milestone Scientific's mailing address is 425 Eagle Rock Avenue Suite 403, Roseland NJ, 07068. The official website for the company is www.milestonescientific.com. The company can be reached via phone at (973) 535-2717, via email at mlss@crescendo-ir.com, or via fax at 973-535-2829. This page (NYSE:MLSS) was last updated on 9/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.